Bridging group | Control group | p value1 | ||
---|---|---|---|---|
Thromboembolic events [n, %] | 2 (0.8%) | 5 (1.9%) | 0.45 | |
Postoperative bleeding2 | Major [n, %] | 22 (8.4%) | 2 (0.8%) | < 0.0001 |
Minor [n, %] | 36 (13.7%) | 14 (5.3%) | 0.001 | |
Red blood cell transfusion [n, %] | 23 (8.7%) | 2 (0.8%) | < 0.0001 | |
Reoperation [n, %] | 40 (15.2%) | 14 (5.4%) | < 0.0001 | |
Classification of complications3 | Grade IIIa–V [n, %] | 61 (23.2%) | 33 (12.5%) | 0.001 |
Grade IVa–V [n, %] | 18 (6.8%) | 8 (3%) | 0.044 | |
In-hospital mortality [n, %] | 4 (1.5%) | 5 (1.9%) | 1.0 | |
Intermediate care/intensive care [n, %] | 118 (44.9%) | 74 (28.1%) | < 0.0001 | |
Length of stay [days] | 12 ± 11 | 9 ± 9 | 0.009 |